Antimalarial prophylaxis - Use and adverse events in visitors to the Kruger National Park

South African Medical Journal

Volumn 89, Issue 2, 1999, Pages 170-175

  Durrheim, D N ^a   Gammon, S ^c   Waner, S ^b   Braack, L E O ^c  

^a Mpumalanga Department of Health and Social Services   (South Africa)

^b NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE; PROGUANIL;

ANXIETY; ARTICLE; DEPRESSION; DIARRHEA; DRUG USE; GASTROINTESTINAL SYMPTOM; HUMAN; MALARIA; MOUTH ULCER; PATIENT COUNSELING; RETROSPECTIVE STUDY; RISK; SOUTH AFRICA; TRAVEL; VERTIGO;

ANTIMALARIALS; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SOUTH AFRICA; TRAVEL;

EID: 0033055637     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. World Health Organisation. International Travel and Health. Vaccination Requirements and Health Advice. Geneva: WHO, 1997: 37.
2. Kruger P, Durrheim DN, Hansford CF. Increasing chloroquine resistance - the Mpumalanga Lowveld story, 1990-1995. S Afr Med J 1996; 86: 280-281.
3. Department of Health. Guidelines for the Prophylaxis of Malaria. Pretoria: DOH, 1996: 3-6.
4. Bradley DJ, Warhurst DC. Guidelines for the prevention of malaria in travellers from the United Kingdom. Communicable Diseases Report 1997; 7: R138-R152.
5. Centers for Disease Control. Recommendations for the prevention of malaria among travellers. JAMA 1990; 263: 2729-2740.
6. Lobel HO, Keystone JS. Confusion on malaria chemoprophylaxis. Lancet 1994; 343: 183.
7. Baily G, Fraser IS, Dunbar EM, Wilkins EGL. Malaria prophylaxis. Mefloquine should be first choice. BMJ 1993; 307: 1564.
8. Barnes AJ, Ong ELC, Dunbar EM, et al. Failure of chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet 1991; 338: 1338-1339.
9. Behrens RH, Bradley DJ, Snow RW, Marsh K. Impact of UK malaria prophylaxis policy on imported malaria. Lancet 1996; 348: 344-345.
10. Lobel HO, Phillips-Howard PA, Brandling-Bennett AD, et al. Malaria incidence and prevention among European and North American travellers to Kenya. Bull WHO 1990; 68: 209-215.
11. Lobel HO, Miani M, Eng T, et al. Long-term malaria prophylaxis with weekly mefloquine. Lancet 1993; 341: 848-851.
12. Peragallo MS, Sabatinelli G, Majori G, et al. Prevention and morbidity of malaria in non-immune subjects; a case-control study among Italian troops in Somalia and Mozambique, 1992-1994. Trans R Soc Trop Med Hyg 1997; 91: 343-346.
13. Steffen R, Fuchs E, Schildnecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet 1993; 341: 1299-1303.
14. Basco LK, Le Bras J. Antimalarial chemoprophylaxis for west Africa. Lancet 1993; 341: 902-903.
15. Corbett EL. Doherty JF, Behrens RH. Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings. BMJ 1996; 313: 1552.
16. Gozal D, Fadat G, Hengy C Long-term chloroquine-proguanil malaria prophylaxis in a non immune pediatric population. J Pediatr 1991; 118: 142-145.
17. Arthur JD, Shanks GD, Echeverria P. Mefloquine prophylaxis. Lancet 1990; 335: 972.
18. Bjorkman A, Steffen R, Armengaud M, et al. Malaria chemoprophylaxis with mefioquine. Lancet 1991; 337: 1479-1480.
19. Cook GC. Malaria prophylaxis. Mefioquine toxicity should limit its use to treatment alone. BMJ 1995; 311: 190-191.
20. Leggat PA, Heydon JL. Malaria prophylaxis prescribed for travellers from New Zealand. N Z Med J 1997; 110: 319-321.
21. Durrheim DN, Ogunbanjo GA. Blumberg L. Malaria - prevention, recognition and cure. South African Family Practice 1996; 17: 367-374.
22. Steffen R, Heusser R, Machler R, et al. Malaria chemoprophylaxis among European tourists in tropical Africa: use, adverse reactions, and efficacy. Bull WHO 1990; 68: 313-322.
23. Williams A, Lewis DJ. Malaria prophylaxis: postal questionnaire survey of general practitioners in south east Wales. BMJ (Clinical Research Edition) 1987; 295: 1449-1452.
24. Bakke P, Gulsvik A, Lilleng P, et al. Postal survey on airborne occupational exposure and respiratory disorders in Norway; causes and consequences of non-response. J Epidemiol Community Health 1990; 44: 316-320.
25. Hill AB, Hill ID. Bradford Hill's Principles of Medical Statistics. 12th ed. London: Edward Arnold, 1991: 23-33.
26. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ. Comparison of adverse events associated with use of mefioquine and combination ot chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ 1996; 313: 525-528.
27. Davis TM, Dembo LG, Kaye-Eddie SA, et al. Neurological, cardiovascular and metabolic effects of mefloquine in healthy volunteers: a double-blind, placebo-controlled trial. Br J Clin Pharmacol 1996; 42: 415-421.
28. Lench P. Malaria prophylaxis: psychological problems after mefloquine and chloroquine. BMJ 1995; 311: 192.
29. McBride SR, Lawrence CM, Pape SA, Reid CA. Fatal toxic epidermal necrolysis associated with mefloquine antimalarial prophylaxis. Lancet 1997; 349: 101.
30. Richter J, Burbach G, Hellgren U, et al. Aberrant atrioventricular conduction triggered by antimalarial prophylaxis with mefloquine Lancet 1997; 349: 101-102.
31. Daniel AM. Mouth ulceration associated with proguanil. Lancet 1986; 1: 269.
32. Drysdale SF, Phillips-Howard PA, Behrens RH. Proguanil, chloroquine, and mouth ulcers. Lancet 1990; 335: 164.
33. Bradley DJ, Three sides of 'the box' BMJ 1994; 309: 347.
34. Bradley DJ, Warhurst D. Travellers' malaria risks. BMJ 1994; 309: 343.
35. Clift S, Grabowski P. Malaria prophylaxis and the media. Lancet 1996; 348: 344.
36. Hill DR. Pre-travel health, immunization status, and demographics ot travel to the developing world for individuals visiting a travel medicine service Am J Trop Med Hyg 1991; 45: 263-270
37. World Health Organisation. Malaria prophylaxis for travellers. Wkly Epidemiol Rec 1993; 68: 377-383.
38. Behrens RH Chloroquine and proguanil prophylaxis in travellers to Kenya. Lancet 1992; 339: 63.
39. Milord F, Allard R, Gyorkos TW. Malaria chemoprophylaxis. Lancet 1993; 342: 502.
40. Sackett DL, Haynes RB. eds.Compliance with Therapeutic Regimens. Baltimore: Johns Hopkins University Press, 1976.
41. Mullen PD. Compliance becomes concordance BMJ 1997; 314: 691-692.